BBLG insider transaction filings
Bone Biologics Corp — 15 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-01-21. Screen BBLG transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for BBLG between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Bone Biologics Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-21 | 4 | Walsh Deina H — Chief Financial Officer | Grant/award (A): 8,335 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Frelick Jeff — Chief Executive Officer | Grant/award (A): 16,668 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Stroever Bruce — Director | Grant/award (A): 62,894 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Meikle Phillip Terry II — Director | Grant/award (A): 62,894 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Gagnon Robert E. — Director | Grant/award (A): 62,894 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Angle Siddhesh Rajendra — Director | Grant/award (A): 62,894 (derivative) @ $0 | EDGAR |
| 2025-01-21 | 4 | Frelick Jeff — Chief Executive Officer | Grant/award (A): 54,110 (derivative) @ $0 | EDGAR |
| 2025-01-21 | 4 | Walsh Deina H — Chief Financial Officer | Grant/award (A): 27,055 (derivative) @ $0 | EDGAR |
| 2024-10-18 | 4 | Meikle Phillip Terry II — Director | Grant/award (A): 9 (derivative) @ $0 · Grant/award (A): 28,185 (derivative) @ $0 | EDGAR |
| 2024-09-19 | 4 | Stroever Bruce — Director | Grant/award (A): 30,713 (derivative) @ $0 | EDGAR |
| 2024-09-19 | 4 | Gagnon Robert E. — Director | Grant/award (A): 30,713 (derivative) @ $0 | EDGAR |
| 2024-09-19 | 4 | Angle Siddhesh Rajendra — Director | Grant/award (A): 30,713 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Walsh Deina H — Chief Financial Officer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Frelick Jeff — Chief Executive Officer | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | Gagnon Robert E. — Director | Grant/award (A): 9 (derivative) @ $0 · Grant/award (A): 8.01 (derivative) @ $0 | EDGAR |
Recent 8-K events — Bone Biologics Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-16 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-07-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-26 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-06 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BBLG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →